Zosano Pharma (ZSAN) Misses Q2 EPS by 10c

Zosano Pharma (NASDAQ: ZSAN) reported Q2 EPS of ($0.63), $0.10 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $68 thousand versus the consensus estimate of $1.78 million.

For earnings history and earnings-related data on Zosano Pharma (ZSAN) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Wendy's U.S. president to resign, company to create COO role
• Royal Unibrew reports higher interim first-half profit as margins improve